K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Caroline Robert
also known as C ROBERT, C Robert, C Robert-Knebelmann
SRM Institute of Science and Technology · Inserm · Université Paris-Saclay · Institut Gustave Roussy
About this author
Works
1,477
Cited by
158,478
h-index
155
i10
567
ORCID ↗
Top papers
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott, et al.
·
2010
·
New England Journal of Medicine
↗ 15,080
OA
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert, et al.
·
2011
·
New England Journal of Medicine
↗ 7,670
OA
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, et al.
·
2014
·
Nature
↗ 6,585
OA
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long, et al.
·
2015
·
New England Journal of Medicine
↗ 5,806
OA
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady, et al.
·
2014
·
New England Journal of Medicine
↗ 5,328
OA
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, et al.
·
2011
·
New England Journal of Medicine
↗ 4,456
OA
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Omid Hamid, Caroline Robert, Adil Daud, et al.
·
2013
·
New England Journal of Medicine
↗ 3,390
OA
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère, et al.
·
2015
·
Science
↗ 3,361
OA
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow, Jason Chesney, Anna C. Pavlick, et al.
·
2015
·
New England Journal of Medicine
↗ 2,756
OA
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert, Bogusława Karaszewska, Jacob Schachter, et al.
·
2014
·
New England Journal of Medicine
↗ 2,638
OA
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
John B.A.G. Haanen, Franck Carbonnel, Caroline Robert, et al.
·
2017
·
Annals of Oncology
↗ 2,331
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty, Caroline Robert, Peter Hersey, et al.
·
2012
·
New England Journal of Medicine
↗ 2,136
OA